Medical cannabis patients in Alabama will be allowed to purchase up to 60 days’ worth of cannabis products at a time and legally possess up to 70 days’ worth, state Medical Cannabis Commission Member Sam Blackmore told the agency last week, according to the Alabama Political Reporter. The program will include maximum doses of 75 milligrams of THC per day for adults and a 3% THC maximum potency for minors.
Blackmore indicated, though, that those limits could be adjusted on a per-patient basis.
“Neurologists treat to effect. When it comes to products, you’re going to treat to an effect, not to a packaged labeling. Practicing neurologists would submit in writing why they are exceeding the maximum dose.” — Blackmore, to the commission, via the Political Reporter
Blackmore said that the correct dose for patients is the “lowest that produces a therapeutic benefit without associated adverse events.”
During the presentation, Blakemore said that topical THC creams were the cheapest per unit at $1.13 per milliliter, with the typical package containing 30 milliliters, while sublingual sprays were at the other end of the spectrum at $3.89 per milliliter, which makes the standard 15-milliliter package run $58.29. Capsules available in medical cannabis programs throughout the U.S. averaged $1.39 each, while lozenges cost $1.33 each.
“It’s important not to focus on high-end products, to ensure there are affordable options,” Blakemore said during his remarks. “Price transparency is important. We need to do anything we can to ensure patient affordability, so they’re not just getting certified by a physician and then going back to the black market.”
The commission is still holding meetings on rules and regulations for Alabama’s medical cannabis program. Its next meeting is set for December 9.